Cargando…

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study

Background: A less effective nomogram for patients with intermediate-stage hepatocellular carcinoma (HCC) to predict overall survival (OS) is available. This study aimed to investigate the role of age-male-albumin-bilirubin-platelet (aMAP) scores in the prognosis of patients with intermediate-stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yaying, Shi, Yanhong, Lu, Linbin, Wang, Xuewen, Lin, Qin, Lin, Yihong, Wang, Ruiqi, Zhu, Hongwu, Zheng, Peichan, Chen, Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240665/ https://www.ncbi.nlm.nih.gov/pubmed/37283795 http://dx.doi.org/10.7150/jca.79377

Ejemplares similares

Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
por: Lu, Linbin, et al.
Publicado: (2021)

Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study
por: Lu, linbin, et al.
Publicado: (2020)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
por: Johnson, Philip J., et al.
Publicado: (2022)

Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
por: Gong, Baocuo, et al.
Publicado: (2023)

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
por: Ohama, Hideko, et al.
Publicado: (2023)

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
por: Gui, Honglian, et al.
Publicado: (2021)

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
por: Yang, Yi, et al.
Publicado: (2021)

Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study
por: Lu, Linbin, et al.
Publicado: (2022)

Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study
por: Lu, Linbin, et al.
Publicado: (2020)

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
por: Qian, Yunsong, et al.
Publicado: (2022)

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Sun, Yunqing, et al.
Publicado: (2022)

Latent Class Analysis of Subphenotypes in Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Chen, Siyu, et al.
Publicado: (2022)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data
por: Niedworok, Christian J., et al.
Publicado: (2016)

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Xuewen, et al.
Publicado: (2020)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

Decision curve analysis to identify optimal candidates of liver resection for intermediate-stage hepatocellular carcinoma with hepatitis B cirrhosis: A cohort study
por: Li, He, et al.
Publicado: (2022)

Enhancing the usability and performance of structured association mapping algorithms using automation, parallelization, and visualization in the GenAMap software system
por: Curtis, Ross E, et al.
Publicado: (2012)

iAMAP-SCM: A Novel Computational Tool for Large-Scale Identification of Antimalarial Peptides Using Estimated Propensity Scores of Dipeptides
por: Charoenkwan, Phasit, et al.
Publicado: (2022)

GWAS in a Box: Statistical and Visual Analytics of Structured Associations via GenAMap
por: Xing, Eric P., et al.
Publicado: (2014)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

The role of the Arctic Monitoring and Assessment Programme (AMAP) in reducing pollution of the Arctic and around the globe
por: Reiersen, Lars-Otto, et al.
Publicado: (2023)

Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population‐based study
por: Chen, Hong, et al.
Publicado: (2022)

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)

AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions
por: Tien, Dat Nguyen, et al.
Publicado: (2014)

Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)
por: Sabe, Hisataka, et al.
Publicado: (2009)

Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma：A Propensity Score Matching Analysis
por: Qiu, Zhiyu, et al.
Publicado: (2019)

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015)

Management of patients with intermediate stage hepatocellular carcinoma
por: Prince, David, et al.
Publicado: (2020)

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy
por: Kinoshita, Rumiko, et al.
Publicado: (2013)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
por: Zhou, Qunfang, et al.
Publicado: (2020)

Altered muscle activation patterns (AMAP): an analytical tool to compare muscle activity patterns of hemiparetic gait with a normative profile
por: Srivastava, Shraddha, et al.
Publicado: (2019)

High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer
por: Tsutaho, Akio, et al.
Publicado: (2020)

GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis
por: Hashimoto, Ari, et al.
Publicado: (2011)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis
por: Ramaswami, Ramya, et al.
Publicado: (2016)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
por: Liu, Furong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6mkndoijclemrhjl16guru7o3i